Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 273, Issue 11, pp 3795–3801 | Cite as

A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux

  • Chunhui Wei
Laryngology

Abstract

We aimed to systematically review the randomized controlled trials (RCTs) regarding the therapeutic efficiency of proton pump inhibitor (PPI) therapy for laryngopharyngeal reflux (LPR). Randomized and placebo-controlled trials regarding the therapeutic efficacy of PPIs on LPR patients were systematically searched from MEDLINE, Cochrane Library, and EMBASE. Data were extracted from eligible studies meeting the inclusion criteria. Heterogeneity among these eligible studies was evaluated by the Q-statistic and I 2 test, based on which a fixed- or random-effects model was performed to pooled relative risks (RRs) for the response rate and standardized mean differences (SMDs) for reflux symptom index (RSI) and the reflux finding score (RFS). Potential publication bias was evaluated by trim and fill method. Totally, 13 RCTs including 831 LPR patients were eligible for this meta-analysis. Pooled results demonstrated that the total RSI significantly improved for patients who received PPI therapy by comparing with those receiving placebo (SMD = 3.65; 95 % CI 1.56–5.75), though no significant difference was found in response rate (RR = 0.04, 95 % CI −0.06 to 0.14) and RFS (SMD = 0.91; 95 % CI −0.53 to 2.35) between these two groups of patients. No publication bias was found among eligible studies. PPI treatment could significantly improve reflux symptoms in LPR patients and, therefore, should be taken into consideration for LPR management with other strategies, such as lifestyle modification.

Keywords

Proton pump inhibitor Laryngopharyngeal reflux Meta-analysis 

Notes

Compliance with ethical standards

Funding

None.

Conflict of interest

All the authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Koufman JA, Aviv JE, Casiano RR, Shaw GY (2002) Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 127(1):32–35CrossRefPubMedGoogle Scholar
  2. 2.
    PhD KWAM, Ba RMS, Ma CSL, Weiss KB (2005) Changing impact of gastroesophageal reflux in medical and otolaryngology practice. Laryngoscope 115(7):1145–1153CrossRefGoogle Scholar
  3. 3.
    Vaezi MF (2003) Gastroesophageal reflux disease and the larynx. J Clin Gastroenterol 36(3):198–203CrossRefPubMedGoogle Scholar
  4. 4.
    Ali-Mel S (2008) Laryngopharyngeal reflux: diagnosis and treatment of a controversial disease. Curr Opin Allergy Clin Immunol 8(1):28–33CrossRefGoogle Scholar
  5. 5.
    Johnson D (2008) Medical therapy of reflux laryngitis. J Clin Gastroenterol 42(5):589–593CrossRefPubMedGoogle Scholar
  6. 6.
    Koufman J, Sataloff RT, Toohill R (1996) Laryngopharyngeal reflux: consensus conference report. J Voice 10(10):215–216CrossRefPubMedGoogle Scholar
  7. 7.
    Koufman JA, Aviv JE, Casiano RR, Shaw GY (2002) Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 127(1):32–35CrossRefGoogle Scholar
  8. 8.
    Ford CN (2005) Evaluation and management of laryngopharyngeal reflux. J Am Med Assoc 294(12):1534–1540CrossRefGoogle Scholar
  9. 9.
    Reichel O, Keller J, Rasp G, Hagedorn H, Berghaus A (2007) Efficacy of once-daily esomeprazole treatment in patients with laryngopharyngeal reflux evaluated by 24-h pH monitoring. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 136(2):205–210. doi: 10.1016/j.otohns.2006.10.011 CrossRefGoogle Scholar
  10. 10.
    Karkos PD, Wilson JA (2006) Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. Laryngoscope 116(1):144–148CrossRefPubMedGoogle Scholar
  11. 11.
    Sen P, Georgalas C, Bhattacharyya AK (2006) A systematic review of the role of proton pump inhibitors for symptoms of laryngopharyngeal reflux. Clin Otolaryngol 31(1):20–24CrossRefPubMedGoogle Scholar
  12. 12.
    Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF (2000) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Br J Surg 87(11):1448–1454CrossRefPubMedGoogle Scholar
  13. 13.
    Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463CrossRefPubMedGoogle Scholar
  14. 14.
    Chappity P, Kumar R, Deka RC, Chokkalingam V, Saraya A, Sikka K (2014) Proton pump inhibitors versus solitary lifestyle modification in management of laryngopharyngeal reflux and evaluating who is at risk: scenario in a developing country. Clin Med Insights Ear Nose Throat 7(7):1–5CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Steward DL, Wilson KM, Dan HK, Patil MS, Schwartzbauer HR, Long JD, Welge JA (2004) Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngology Head Neck Surg 131(4):342–350CrossRefGoogle Scholar
  16. 16.
    Lam PK, Ng ML, Cheung TK, Wong BY, Tan VP, Fong DY, Wei WI, Wong BC (2010) Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 8(9):770–776Google Scholar
  17. 17.
    Fass R, Noelck N, Willis MR, Navarro-Rodriguez T, Wilson K, Powers J, Barkmeier-Kraemer JM (2010) The effect of esomeprazole 20 mg twice daily on acoustic and perception parameters of the voice in laryngopharyngeal reflux. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 22(2):44–45Google Scholar
  18. 18.
    Ours TM, Kavuru MS, Schilz RJ, Richter JE (1999) A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 94(11):3131–3138. doi: 10.1111/j.1572-0241.1999.01504.x CrossRefPubMedGoogle Scholar
  19. 19.
    Oliver R, Holger D, Katrin WN, Issing WJ (2008) Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux. Otolaryngol Head Neck Surg 139(3):414–420CrossRefGoogle Scholar
  20. 20.
    Wo JM, Jennifer K, Harrell SP, Ken P, Welby W, Eric L (2006) Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol 101(9):1972–1978CrossRefPubMedGoogle Scholar
  21. 21.
    Vaezi MF, Richter JE, Stasney CR, Spiegel JR, Iannuzzi RA, Crawley JA, Clara H, Sostek MB, Reza S (2006) Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 116(2):254–260CrossRefPubMedGoogle Scholar
  22. 22.
    Eherer AJ, Habermann W, Hammer HF, Kiesler K, Friedrich G, Krejs GJ (2003) Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 38(5):462–467CrossRefPubMedGoogle Scholar
  23. 23.
    Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF, Levine PA (2001) Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 111(12):2147–2151CrossRefPubMedGoogle Scholar
  24. 24.
    El-Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, Mccarthy DM (2001) Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 96(4):979–983CrossRefPubMedGoogle Scholar
  25. 25.
    Shaheen NJ, Crockett SD, Bright SD, Madanick RD, Buckmire R, Couch M, Dellon ES, Galanko JA, Sharpless G, Morgan DR (2011) Randomised clinical trial: high-dose acid suppression for chronic cough—a double-blind, placebo-controlled study. Aliment Pharmacol Ther 33(2):225–234CrossRefPubMedGoogle Scholar
  26. 26.
    Luo H, Ma S, Gao Y, Yan J, Hou J, Xu M (2015) The therapeutic effect of proton pump inhibitor on alleviation of hoarseness symptoms in patients with laryngopharyngeal reflux. J Clin Otorhinolaryngol Head Neck Surg 29(11):997–1001Google Scholar
  27. 27.
    Athanasia P, Athanassios K, Eirini O, Stefanos T (2011) Assessing laryngopharyngeal reflux symptoms with the Reflux Symptom Index: validation and prevalence in the Greek population. Otolaryngol Head Neck Surg 145(6):974–980CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.Otolaryngology-Head Neck SurgeryBeijing Friendship Hospital Attached of Capital Medical UniversityBeijingChina

Personalised recommendations